Sensyne Health + Chelsea and Westminster Hospital NHS Foundation Trust sign Strategic Research Agreement for Clinical AI
Lloyd Price
AUGUST 5, 2018
New agreement enables analysis of anonymised patient data using clinical artificial intelligence technology to accelerate medical research, help find new treatments and improve patient care. Sensyne Health Limited (the "Company"), formerly Drayson Health, a British clinical AI technology company, announces today that it has signed a Strategic Research Agreement (SRA) with Chelsea and Westminster Hospital NHS Foundation Trust.
Let's personalize your content